aluates Reports

$ 0.0

Automative

Global Pharmaceutical Intermediate CDMO Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-31T14929

Global Pharmaceutical Intermediate CDMO Market Research Report 2023

BUY CHAPTERS

Global Pharmaceutical Intermediate CDMO Market Research Report 2025

Code: QYRE-Auto-31T14929

Report

May 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

WR Grace

AGC Pharma Chemicals

Evonik

CordenPharma

Otsuka Chemical

Wavelength

KBI Biopharma

Chengda Pharmaceuticals

Apeloa Pharmaceutical

Xi'an Manareco New Materials

Chengdu D-Innovation Pharmaceutical

Huateng Pharma

Esteve Química

Shenzhen Sungening Bio-technology

Cambrex

Pharmaceutical Intermediate CDMO Market

The global market for Pharmaceutical Intermediate CDMO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Pharmaceutical Intermediate CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pharmaceutical Intermediate CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Pharmaceutical Intermediate CDMO in Pharmaceutical Company is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Pharmaceutical Intermediate CDMO include Cambrex, WR Grace, Esteve Química, AGC Pharma Chemicals, Evonik, CordenPharma, Otsuka Chemical, Wavelength, KBI Biopharma, Chengda Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Intermediate CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Intermediate CDMO.

The Pharmaceutical Intermediate CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Intermediate CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical Intermediate CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmaceutical Intermediate CDMO Market Report

Report Metric	Details
Report Name	Pharmaceutical Intermediate CDMO Market
Segment by Type	Small Molecule Cdmo Macromolecular Cdmo
Segment by Application	Pharmaceutical Company Biotechnology Company Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cambrex, WR Grace, Esteve Química, AGC Pharma Chemicals, Evonik, CordenPharma, Otsuka Chemical, Wavelength, KBI Biopharma, Chengda Pharmaceuticals, Apeloa Pharmaceutical, Xi'an Manareco New Materials, Shenzhen Sungening Bio-technology, Chengdu D-innovation Pharmaceutical, Huateng Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Intermediate CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical Intermediate CDMO Market report?

Ans: The main players in the Pharmaceutical Intermediate CDMO Market are Cambrex, WR Grace, Esteve Química, AGC Pharma Chemicals, Evonik, CordenPharma, Otsuka Chemical, Wavelength, KBI Biopharma, Chengda Pharmaceuticals, Apeloa Pharmaceutical, Xi'an Manareco New Materials, Shenzhen Sungening Bio-technology, Chengdu D-innovation Pharmaceutical, Huateng Pharma

What are the Application segmentation covered in the Pharmaceutical Intermediate CDMO Market report?

Ans: The Applications covered in the Pharmaceutical Intermediate CDMO Market report are Pharmaceutical Company, Biotechnology Company, Others

What are the Type segmentation covered in the Pharmaceutical Intermediate CDMO Market report?

Ans: The Types covered in the Pharmaceutical Intermediate CDMO Market report are Small Molecule Cdmo, Macromolecular Cdmo

Recommended Reports

Small Molecule CDMO

Biologics & Gene CDMO

Full-Service & Specialized CDMO

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical Intermediate CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Small Molecule Cdmo

1.2.3 Macromolecular Cdmo

1.3 Market by Application

1.3.1 Global Pharmaceutical Intermediate CDMO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Company

1.3.3 Biotechnology Company

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical Intermediate CDMO Market Perspective (2020-2031)

2.2 Global Pharmaceutical Intermediate CDMO Growth Trends by Region

2.2.1 Global Pharmaceutical Intermediate CDMO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharmaceutical Intermediate CDMO Historic Market Size by Region (2020-2025)

2.2.3 Pharmaceutical Intermediate CDMO Forecasted Market Size by Region (2026-2031)

2.3 Pharmaceutical Intermediate CDMO Market Dynamics

2.3.1 Pharmaceutical Intermediate CDMO Industry Trends

2.3.2 Pharmaceutical Intermediate CDMO Market Drivers

2.3.3 Pharmaceutical Intermediate CDMO Market Challenges

2.3.4 Pharmaceutical Intermediate CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmaceutical Intermediate CDMO Players by Revenue

3.1.1 Global Top Pharmaceutical Intermediate CDMO Players by Revenue (2020-2025)

3.1.2 Global Pharmaceutical Intermediate CDMO Revenue Market Share by Players (2020-2025)

3.2 Global Pharmaceutical Intermediate CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharmaceutical Intermediate CDMO Revenue

3.4 Global Pharmaceutical Intermediate CDMO Market Concentration Ratio

3.4.1 Global Pharmaceutical Intermediate CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Intermediate CDMO Revenue in 2024

3.5 Global Key Players of Pharmaceutical Intermediate CDMO Head office and Area Served

3.6 Global Key Players of Pharmaceutical Intermediate CDMO, Product and Application

3.7 Global Key Players of Pharmaceutical Intermediate CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Intermediate CDMO Breakdown Data by Type

4.1 Global Pharmaceutical Intermediate CDMO Historic Market Size by Type (2020-2025)

4.2 Global Pharmaceutical Intermediate CDMO Forecasted Market Size by Type (2026-2031)

5 Pharmaceutical Intermediate CDMO Breakdown Data by Application

5.1 Global Pharmaceutical Intermediate CDMO Historic Market Size by Application (2020-2025)

5.2 Global Pharmaceutical Intermediate CDMO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pharmaceutical Intermediate CDMO Market Size (2020-2031)

6.2 North America Pharmaceutical Intermediate CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharmaceutical Intermediate CDMO Market Size by Country (2020-2025)

6.4 North America Pharmaceutical Intermediate CDMO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmaceutical Intermediate CDMO Market Size (2020-2031)

7.2 Europe Pharmaceutical Intermediate CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharmaceutical Intermediate CDMO Market Size by Country (2020-2025)

7.4 Europe Pharmaceutical Intermediate CDMO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmaceutical Intermediate CDMO Market Size (2020-2031)

8.2 Asia-Pacific Pharmaceutical Intermediate CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharmaceutical Intermediate CDMO Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharmaceutical Intermediate CDMO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmaceutical Intermediate CDMO Market Size (2020-2031)

9.2 Latin America Pharmaceutical Intermediate CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharmaceutical Intermediate CDMO Market Size by Country (2020-2025)

9.4 Latin America Pharmaceutical Intermediate CDMO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmaceutical Intermediate CDMO Market Size (2020-2031)

10.2 Middle East & Africa Pharmaceutical Intermediate CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharmaceutical Intermediate CDMO Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharmaceutical Intermediate CDMO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cambrex

11.1.1 Cambrex Company Details

11.1.2 Cambrex Business Overview

11.1.3 Cambrex Pharmaceutical Intermediate CDMO Introduction

11.1.4 Cambrex Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.1.5 Cambrex Recent Development

11.2 WR Grace

11.2.1 WR Grace Company Details

11.2.2 WR Grace Business Overview

11.2.3 WR Grace Pharmaceutical Intermediate CDMO Introduction

11.2.4 WR Grace Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.2.5 WR Grace Recent Development

11.3 Esteve Química

11.3.1 Esteve Química Company Details

11.3.2 Esteve Química Business Overview

11.3.3 Esteve Química Pharmaceutical Intermediate CDMO Introduction

11.3.4 Esteve Química Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.3.5 Esteve Química Recent Development

11.4 AGC Pharma Chemicals

11.4.1 AGC Pharma Chemicals Company Details

11.4.2 AGC Pharma Chemicals Business Overview

11.4.3 AGC Pharma Chemicals Pharmaceutical Intermediate CDMO Introduction

11.4.4 AGC Pharma Chemicals Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.4.5 AGC Pharma Chemicals Recent Development

11.5 Evonik

11.5.1 Evonik Company Details

11.5.2 Evonik Business Overview

11.5.3 Evonik Pharmaceutical Intermediate CDMO Introduction

11.5.4 Evonik Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.5.5 Evonik Recent Development

11.6 CordenPharma

11.6.1 CordenPharma Company Details

11.6.2 CordenPharma Business Overview

11.6.3 CordenPharma Pharmaceutical Intermediate CDMO Introduction

11.6.4 CordenPharma Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.6.5 CordenPharma Recent Development

11.7 Otsuka Chemical

11.7.1 Otsuka Chemical Company Details

11.7.2 Otsuka Chemical Business Overview

11.7.3 Otsuka Chemical Pharmaceutical Intermediate CDMO Introduction

11.7.4 Otsuka Chemical Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.7.5 Otsuka Chemical Recent Development

11.8 Wavelength

11.8.1 Wavelength Company Details

11.8.2 Wavelength Business Overview

11.8.3 Wavelength Pharmaceutical Intermediate CDMO Introduction

11.8.4 Wavelength Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.8.5 Wavelength Recent Development

11.9 KBI Biopharma

11.9.1 KBI Biopharma Company Details

11.9.2 KBI Biopharma Business Overview

11.9.3 KBI Biopharma Pharmaceutical Intermediate CDMO Introduction

11.9.4 KBI Biopharma Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.9.5 KBI Biopharma Recent Development

11.10 Chengda Pharmaceuticals

11.10.1 Chengda Pharmaceuticals Company Details

11.10.2 Chengda Pharmaceuticals Business Overview

11.10.3 Chengda Pharmaceuticals Pharmaceutical Intermediate CDMO Introduction

11.10.4 Chengda Pharmaceuticals Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.10.5 Chengda Pharmaceuticals Recent Development

11.11 Apeloa Pharmaceutical

11.11.1 Apeloa Pharmaceutical Company Details

11.11.2 Apeloa Pharmaceutical Business Overview

11.11.3 Apeloa Pharmaceutical Pharmaceutical Intermediate CDMO Introduction

11.11.4 Apeloa Pharmaceutical Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.11.5 Apeloa Pharmaceutical Recent Development

11.12 Xi'an Manareco New Materials

11.12.1 Xi'an Manareco New Materials Company Details

11.12.2 Xi'an Manareco New Materials Business Overview

11.12.3 Xi'an Manareco New Materials Pharmaceutical Intermediate CDMO Introduction

11.12.4 Xi'an Manareco New Materials Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.12.5 Xi'an Manareco New Materials Recent Development

11.13 Shenzhen Sungening Bio-technology

11.13.1 Shenzhen Sungening Bio-technology Company Details

11.13.2 Shenzhen Sungening Bio-technology Business Overview

11.13.3 Shenzhen Sungening Bio-technology Pharmaceutical Intermediate CDMO Introduction

11.13.4 Shenzhen Sungening Bio-technology Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.13.5 Shenzhen Sungening Bio-technology Recent Development

11.14 Chengdu D-innovation Pharmaceutical

11.14.1 Chengdu D-innovation Pharmaceutical Company Details

11.14.2 Chengdu D-innovation Pharmaceutical Business Overview

11.14.3 Chengdu D-innovation Pharmaceutical Pharmaceutical Intermediate CDMO Introduction

11.14.4 Chengdu D-innovation Pharmaceutical Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.14.5 Chengdu D-innovation Pharmaceutical Recent Development

11.15 Huateng Pharma

11.15.1 Huateng Pharma Company Details

11.15.2 Huateng Pharma Business Overview

11.15.3 Huateng Pharma Pharmaceutical Intermediate CDMO Introduction

11.15.4 Huateng Pharma Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025)

11.15.5 Huateng Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

WR Grace

AGC Pharma Chemicals

Evonik

CordenPharma

Otsuka Chemical

Wavelength

KBI Biopharma

Chengda Pharmaceuticals

Apeloa Pharmaceutical

Xi'an Manareco New Materials

Chengdu D-Innovation Pharmaceutical

Huateng Pharma

Esteve Química

Shenzhen Sungening Bio-technology

Cambrex

List of Tables

Table 1. Global Pharmaceutical Intermediate CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Small Molecule Cdmo

Table 3. Key Players of Macromolecular Cdmo

Table 4. Global Pharmaceutical Intermediate CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Pharmaceutical Intermediate CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Pharmaceutical Intermediate CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Pharmaceutical Intermediate CDMO Market Share by Region (2020-2025)

Table 8. Global Pharmaceutical Intermediate CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Pharmaceutical Intermediate CDMO Market Share by Region (2026-2031)

Table 10. Pharmaceutical Intermediate CDMO Market Trends

Table 11. Pharmaceutical Intermediate CDMO Market Drivers

Table 12. Pharmaceutical Intermediate CDMO Market Challenges

Table 13. Pharmaceutical Intermediate CDMO Market Restraints

Table 14. Global Pharmaceutical Intermediate CDMO Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Pharmaceutical Intermediate CDMO Market Share by Players (2020-2025)

Table 16. Global Top Pharmaceutical Intermediate CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Intermediate CDMO as of 2024)

Table 17. Ranking of Global Top Pharmaceutical Intermediate CDMO Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Pharmaceutical Intermediate CDMO Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Pharmaceutical Intermediate CDMO, Headquarters and Area Served

Table 20. Global Key Players of Pharmaceutical Intermediate CDMO, Product and Application

Table 21. Global Key Players of Pharmaceutical Intermediate CDMO, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Pharmaceutical Intermediate CDMO Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Pharmaceutical Intermediate CDMO Revenue Market Share by Type (2020-2025)

Table 25. Global Pharmaceutical Intermediate CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Pharmaceutical Intermediate CDMO Revenue Market Share by Type (2026-2031)

Table 27. Global Pharmaceutical Intermediate CDMO Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Pharmaceutical Intermediate CDMO Revenue Market Share by Application (2020-2025)

Table 29. Global Pharmaceutical Intermediate CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Pharmaceutical Intermediate CDMO Revenue Market Share by Application (2026-2031)

Table 31. North America Pharmaceutical Intermediate CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Pharmaceutical Intermediate CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Pharmaceutical Intermediate CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Pharmaceutical Intermediate CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Pharmaceutical Intermediate CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Pharmaceutical Intermediate CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Pharmaceutical Intermediate CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Pharmaceutical Intermediate CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Pharmaceutical Intermediate CDMO Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Pharmaceutical Intermediate CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Pharmaceutical Intermediate CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Pharmaceutical Intermediate CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Pharmaceutical Intermediate CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Pharmaceutical Intermediate CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Pharmaceutical Intermediate CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 46. Cambrex Company Details

Table 47. Cambrex Business Overview

Table 48. Cambrex Pharmaceutical Intermediate CDMO Product

Table 49. Cambrex Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 50. Cambrex Recent Development

Table 51. WR Grace Company Details

Table 52. WR Grace Business Overview

Table 53. WR Grace Pharmaceutical Intermediate CDMO Product

Table 54. WR Grace Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 55. WR Grace Recent Development

Table 56. Esteve Química Company Details

Table 57. Esteve Química Business Overview

Table 58. Esteve Química Pharmaceutical Intermediate CDMO Product

Table 59. Esteve Química Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 60. Esteve Química Recent Development

Table 61. AGC Pharma Chemicals Company Details

Table 62. AGC Pharma Chemicals Business Overview

Table 63. AGC Pharma Chemicals Pharmaceutical Intermediate CDMO Product

Table 64. AGC Pharma Chemicals Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 65. AGC Pharma Chemicals Recent Development

Table 66. Evonik Company Details

Table 67. Evonik Business Overview

Table 68. Evonik Pharmaceutical Intermediate CDMO Product

Table 69. Evonik Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 70. Evonik Recent Development

Table 71. CordenPharma Company Details

Table 72. CordenPharma Business Overview

Table 73. CordenPharma Pharmaceutical Intermediate CDMO Product

Table 74. CordenPharma Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 75. CordenPharma Recent Development

Table 76. Otsuka Chemical Company Details

Table 77. Otsuka Chemical Business Overview

Table 78. Otsuka Chemical Pharmaceutical Intermediate CDMO Product

Table 79. Otsuka Chemical Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 80. Otsuka Chemical Recent Development

Table 81. Wavelength Company Details

Table 82. Wavelength Business Overview

Table 83. Wavelength Pharmaceutical Intermediate CDMO Product

Table 84. Wavelength Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 85. Wavelength Recent Development

Table 86. KBI Biopharma Company Details

Table 87. KBI Biopharma Business Overview

Table 88. KBI Biopharma Pharmaceutical Intermediate CDMO Product

Table 89. KBI Biopharma Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 90. KBI Biopharma Recent Development

Table 91. Chengda Pharmaceuticals Company Details

Table 92. Chengda Pharmaceuticals Business Overview

Table 93. Chengda Pharmaceuticals Pharmaceutical Intermediate CDMO Product

Table 94. Chengda Pharmaceuticals Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 95. Chengda Pharmaceuticals Recent Development

Table 96. Apeloa Pharmaceutical Company Details

Table 97. Apeloa Pharmaceutical Business Overview

Table 98. Apeloa Pharmaceutical Pharmaceutical Intermediate CDMO Product

Table 99. Apeloa Pharmaceutical Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 100. Apeloa Pharmaceutical Recent Development

Table 101. Xi'an Manareco New Materials Company Details

Table 102. Xi'an Manareco New Materials Business Overview

Table 103. Xi'an Manareco New Materials Pharmaceutical Intermediate CDMO Product

Table 104. Xi'an Manareco New Materials Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 105. Xi'an Manareco New Materials Recent Development

Table 106. Shenzhen Sungening Bio-technology Company Details

Table 107. Shenzhen Sungening Bio-technology Business Overview

Table 108. Shenzhen Sungening Bio-technology Pharmaceutical Intermediate CDMO Product

Table 109. Shenzhen Sungening Bio-technology Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 110. Shenzhen Sungening Bio-technology Recent Development

Table 111. Chengdu D-innovation Pharmaceutical Company Details

Table 112. Chengdu D-innovation Pharmaceutical Business Overview

Table 113. Chengdu D-innovation Pharmaceutical Pharmaceutical Intermediate CDMO Product

Table 114. Chengdu D-innovation Pharmaceutical Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 115. Chengdu D-innovation Pharmaceutical Recent Development

Table 116. Huateng Pharma Company Details

Table 117. Huateng Pharma Business Overview

Table 118. Huateng Pharma Pharmaceutical Intermediate CDMO Product

Table 119. Huateng Pharma Revenue in Pharmaceutical Intermediate CDMO Business (2020-2025) & (US$ Million)

Table 120. Huateng Pharma Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Pharmaceutical Intermediate CDMO Picture

Figure 2. Global Pharmaceutical Intermediate CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharmaceutical Intermediate CDMO Market Share by Type: 2024 VS 2031

Figure 4. Small Molecule Cdmo Features

Figure 5. Macromolecular Cdmo Features

Figure 6. Global Pharmaceutical Intermediate CDMO Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Pharmaceutical Intermediate CDMO Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical Company Case Studies

Figure 9. Biotechnology Company Case Studies

Figure 10. Others Case Studies

Figure 11. Pharmaceutical Intermediate CDMO Report Years Considered

Figure 12. Global Pharmaceutical Intermediate CDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Pharmaceutical Intermediate CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Pharmaceutical Intermediate CDMO Market Share by Region: 2024 VS 2031

Figure 15. Global Pharmaceutical Intermediate CDMO Market Share by Players in 2024

Figure 16. Global Top Pharmaceutical Intermediate CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Intermediate CDMO as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Intermediate CDMO Revenue in 2024

Figure 18. North America Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Pharmaceutical Intermediate CDMO Market Share by Country (2020-2031)

Figure 20. United States Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Pharmaceutical Intermediate CDMO Market Share by Country (2020-2031)

Figure 24. Germany Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Pharmaceutical Intermediate CDMO Market Share by Region (2020-2031)

Figure 32. China Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Pharmaceutical Intermediate CDMO Market Share by Country (2020-2031)

Figure 40. Mexico Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Pharmaceutical Intermediate CDMO Market Share by Country (2020-2031)

Figure 44. Turkey Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Pharmaceutical Intermediate CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Cambrex Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 48. WR Grace Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 49. Esteve Química Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 50. AGC Pharma Chemicals Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 51. Evonik Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 52. CordenPharma Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 53. Otsuka Chemical Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 54. Wavelength Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 55. KBI Biopharma Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 56. Chengda Pharmaceuticals Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 57. Apeloa Pharmaceutical Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 58. Xi'an Manareco New Materials Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 59. Shenzhen Sungening Bio-technology Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 60. Chengdu D-innovation Pharmaceutical Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 61. Huateng Pharma Revenue Growth Rate in Pharmaceutical Intermediate CDMO Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Innovative Drug CDMO Market Research Report 2024

Global Small Molecule Innovator CDMO Market Research Report 2025

Global Chemical API CDMO Market Research Report 2024

Small Molecule CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical CDMO Pharmaceutical Contract Development and Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Exosome CDMO Market Research Report 2024

Global Cell Therapy CDMO Market Research Report 2025

Active Pharmaceutical Ingredients CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Peptide CDMO Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025

Global Cell and Gene Therapy CDMO Market Research Report 2024

Global CMO and CDMO biotechnology Market Research Report 2024

Global Microbial CDMO Service Market Research Report 2024

Softgel CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Device CDMO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mammalian CDMO Service Market Research Report 2024

Global Gene Cell Therapy CDMO Market Research Report 2024

Global Plasmid CDMO Services Market Research Report 2025

Global Cellular and Gene Therapy CDMO Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions